Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Masae Ishiguro"'
Publikováno v:
Microbiology and Immunology. 60:47-55
Performance status (PS) frequently improves occurs in cancer patients who have been infused with their own lymphokine-activated killer T cells (LAK-T). In the present study, a culture supernatant of LAK-T (LAK-T sup) administered to 8-week-old rats c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4631ef619c4ab3a290655ded9e0e272
https://doi.org/10.1111/1348-0421.12346
https://doi.org/10.1111/1348-0421.12346
Autor:
Takanobu Otsuka, Kiyohide Kojima, Jun Mizutani, Waguri Nagaya Yuko, Hidechika Okada, Aiharu Furuya, Masae Ishiguro
Publikováno v:
Thermal Medicine. 26:19-29
Radiofrequency hyperthermia has been widely and successfully used for treatment of malignant tumors. Metastatic tumors are suppressed in some patients harboring malignant tumors during primary tumor treatment with hyperthermia. In the present study,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e08c988db053e1d80827296b195631b
https://doi.org/10.3191/thermalmed.26.19
https://doi.org/10.3191/thermalmed.26.19
Publikováno v:
Microbiology and immunology. 60(1)
Performance status (PS) frequently improves occurs in cancer patients who have been infused with their own lymphokine-activated killer T cells (LAK-T). In the present study, a culture supernatant of LAK-T (LAK-T sup) administered to 8-week-old rats c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::829ef628f1d8e82a68f18f51c12e4572
https://pubmed.ncbi.nlm.nih.gov/26616436
https://pubmed.ncbi.nlm.nih.gov/26616436
Autor:
Noriyasu Kawai, K. Kohri, Kaoru Saitou, Kousuke Ueda, Takehiko Okamura, Masae Ishiguro, Kazuhiro Tajima
Publikováno v:
Thermal Medicine(Japanese Journal of Hyperthermic Oncology). 14:41-45
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61b56ebc8151601f7258b2db26cc1418
https://doi.org/10.3191/thermalmedicine.14.41
https://doi.org/10.3191/thermalmedicine.14.41
Autor:
Takayuki Yamamoto, Noriko Okada, Norihiro Ogawa, Takeshi Kanesaka, Hiroyasu Akatsu, Masae Ishiguro, William Campbell, Hidechika Okada
Publikováno v:
Microbiology and immunology. 51(5)
Thrombin-activatable fibrinolysis inhibitor (TAFI) is an anaphylatoxin-inactivating enzyme generated by proteolytic cleavage of its zymogen, and is the same enzyme as that first designated by our group as procarboxypeptidase R (proCPR). TAFI in plasm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b02b0bacfee3437ab23c7735476d4b20
https://pubmed.ncbi.nlm.nih.gov/17579260
https://pubmed.ncbi.nlm.nih.gov/17579260
Publikováno v:
Microbiology & Immunology; Jan2016, Vol. 60 Issue 1, p47-55, 9p
The regulation of the organism has traditionally been ascribed to two distinct systems-the nervous and the endocrine. Though coordination between the two systems has been acknowledged, researchers and authors have tended to deal with them as comprisi
